trensox

Known as: O-trensox, tris-N-(2-(8-hydroxyquinoline-5-sulfonato-7-carboxamido)ethyl)amine, tris-N-(2-aminoethyl-(8-hydroxyquinoline-5-sulphonato-7-carboxamido))amine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2012
01219982012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
If a new generation of iron chelators specifically devoted for cancer chemotherapy emerged these last years, any of them has not… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2006
2006
By comparing the antiproliferative effect of the iron chelators ICL670A and O-trensox in the human hepatoma cell line HUH7 and… (More)
Is this relevant?
2006
2006
The antiproliferative effects of the iron chelator O-trensox and the ornithine-decarboxylase (ODC) inhibitor alpha… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2000
2000
We investigated the effects of a new iron chelator, O-Trensox (TRX), compared with desferrioxamine (DFO), on proliferation and… (More)
Is this relevant?
1998
1998
We tested a new synthetic, 8-hydroxyquinoline-based, hexadentate iron chelator, O-Trensox and compared it with desferrioxamine B… (More)
Is this relevant?